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Dengue virus type 2 (DEN2), a member of the Flaviviridae family of positive-strand RNA viruses, contains a single RNA
genome having a type I cap structure at the 5 end. The viral RNA is translated to produce a single polyprotein precursor that
is processed to yield three virion proteins and at least seven nonstructural proteins (NS) in the infected host. NS3 is a
multifunctional protein having a serine protease catalytic triad within the N-terminal 180 amino acid residues which requires
NS2B as a cofactor for activation of protease activity. The C-terminal portion of this catalytic triad has conserved motifs
present in several nucleoside triphosphatases (NTPases)/RNA helicases. In addition, subtilisin-treated West Nile (WN) virus
NS3 from infected cells was reported to have 5-RNA triphosphatase activity, suggesting its role in the synthesis of the 5-cap
structure. In this study, full-length DEN2 NS3 was expressed with an N-terminal histidine tag in Escherichia coli and purified
in a soluble form. The purified protein has 5-RNA triphosphatase activity that cleaves the -phosphate moiety of theINTRODUCTION
The flavivirus family, of which dengue viruses (DEN)
(types 1–4) are important members, has the widest geo-
graphic distribution and highest incidence of infection of
the human population (Gubler and Trent, 1993; Hayes
and Gubler, 1992; Lanciotti et al., 1994; Rigau-Perez et al.,
1994). These mosquito-borne viruses cause dengue fe-
ver, dengue hemorrhagic fever (DHF), and dengue shock
syndrome (DSS). These diseases have emerged as sig-
nificant threats to human health in affected areas, and
are most prevalent in tropical and subtropical regions
where the environmental conditions are favorable for
survival of the vector organism, Aedes aegypti. As a
result of the expanded range of this mosquito, an esti-
mated 2.5 billion people are threatened by dengue virus
infection (Leyssen et al., 2000).
Dengue viruses contain a positive-strand genomic
RNA consisting of a single open-reading frame (ORF)
(10173 nt in length for DEN2 New Guinea C strain (Irie et
al., 1989)). The 5-end of the genomic RNA is modified
with a (m7GpppN) cap. The genomic RNA encodes a
single polyprotein precursor that is processed to yield
three structural (C, prM, and E) and at least seven non-
structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and
NS5) proteins (for reviews, see Chambers et al., 1990a;
Rice, 1996; and references therein).
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122DEN2 NS3 is a multifunctional protein of approxi-
mately 69 kDa involved in polyprotein processing, and is
thought to play a role in RNA replication and capping of
the viral genomic RNA. The NS3 serine protease domain
is contained within the N-terminal 180 amino acids and
requires the protein NS2B for protease activity (Cham-
bers et al., 1990b; Falgout et al., 1991; Wengler et al.,
1991; Zhang et al., 1992). Furthermore, the conserved
hydrophilic domain of NS2B alone is sufficient for acti-
vation of the protease domain of NS3 (Falgout et al.,
1993; Clum et al., 1997).
NS3 also has several conserved domains found in the
DEXH family of RNA helicases/NTPases (Gorbalenya et
al., 1989). The NTPase activity of flavivirus NS3 has been
extensively characterized for several flaviviruses, includ-
ing DEN2 (Li et al., 1999; Suzich et al., 1993; Warrener et
al., 1993; Wengler and Wengler, 1991). RNA helicase
activity of NS3 has also been demonstrated for HCV
(Gwack et al., 1996; Jin and Peterson, 1995; Kim et al.,
1995, 1997; Tai et al., 1996), dengue virus (Li et al., 1999),
Japanese encephalitis virus (Utama et al., 2000), and
pestivirus proteins (Warrener and Collett, 1995).
In addition to the NTPase/RNA helicase activities of
NS3 protein, a N-terminally truncated fragment of West
Nile virus (WN)2 NS3 has been shown to act as a RNA
2 Abbreviations used: IPTG, isopropyl--D-thiogalactopyranoside;
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5-triphosphatase in vitro (Wengler and Wengler, 1993).
The 5 (m7GpppN)-cap structure of cellular and viral
mRNAs is formed by a similar mechanism involving three
enzymatic reactions: the 5-triphosphate terminus of a
primary transcript is first cleaved to a diphosphate-ter-
minated RNA by RNA 5-triphosphatase (RTPase), then
capped with GMP by RNA guanylyltransferase, and
methylated at the N7 position of guanine by RNA (gua-
nine-7)methyltransferase (Shuman, 1995). Flaviviruses
replicate in the cytoplasm of infected cells and they are
believed to encode their own capping enzymes. Since
the proteolytic fragment of WN virus NS3 has the RTPase
activity, it is thought to play a role in 5-capping of
flavivirus RNA (Wengler and Wengler, 1993). However,
the origin of the guanylyltransferase activity is not
known. NS5 contains a conserved S-adenosylmethi-
onine-utilizing methyltransferase domain in its N-termi-
nal region, but this activity has not been demonstrated in
vitro (Koonin, 1993).
Furthermore, the RNA 5-triphosphatase activity of full-
length NS3 for any flavivirus has not been previously
studied. Therefore, in this study, we expressed the full-
length NS3 with a histidine tag at its N-terminus in
Escherichia coli and purified the protein in a soluble
form. Mutational analysis of conserved residues in the
5-terminal recognition element (TRE), previously thought
to play a role in 5-RTPase active site (Wengler and
Wengler, 1993), and subsequent expression and purifi-
cation of the mutant proteins in E. coli revealed that the
5-TRE plays no role in 5-RTPase activity. Our results
indicate that the RTPase activity of NS3 is independent of
a divalent metal ion requirement. The RTPase is inhibited
by high ionic strength and by ATP in a dose-dependent
manner. Our results, taken together, suggest that the
5-RTPase and NTPase activities share a common active
site. Since capping of the flavivirus RNA genome is a
necessary step in the viral replication process, the flavi-
virus capping machinery poses an attractive target for
antiviral treatments.
RESULTS
Expression and purification of full-length NS3 protein
NS3 was purified from the soluble fraction of E. coli
XL1-Blue transformed with an NS3 expression plasmid.
Initial attempts to express full-length NS3 were unsuc-
cessful due to leakiness of the lac promoter and toxicity
of small quantities of NS3 produced during the initial
growth phase of E. coli. Addition of glucose and the
absence of the IPTG inducer during initial growth of E.
coli tightly repressed the lac operon/promoter due to
reduction of cAMP and catabolite activator protein levels
(due to “catabolite repression”). After E. coli growth
reached sufficient levels, glucose was removed, and
cells were induced with IPTG and incubated at a lower
temperature (30°C). This protocol gave rise to an in-
creased proportion of full-length NS3 in the soluble form.
The wild-type NS3 protein was purified by metal-affinity
chromatography followed by gel-filtration chromatogra-
phy which allowed for purification of the wild-type en-
zyme to greater than 95% purity (Fig. 1). However, the
mutant proteins were produced at lower levels. Their
purity was estimated by densitometric scanning of the
Coomassie blue-stained gels and quantification was
found to be 43 and 46% for K199E and K592A, respec-
tively, and 38% for the L591A mutant NS3 protein (Fig. 1C).
Demonstration of the RNA 5-triphosphatase activity
of NS3
The RTPase activity was assayed using thin-layer
chromatography (TLC) on a polyethyleneimine (PEI) sup-
port as described under Materials and Methods. The
purified wild-type NS3 protein catalyzed the cleavage of
a -32P-labeled phosphate group from a triphosphory-
lated RNA substrate. The RTPase activity was measured
as the percentage of [32Pi] released at various incubation
times. This activity was proportional to enzyme concen-
tration and was not present in control assays lacking
NS3 (Fig. 2). The turnover number of the enzyme is
calculated to be 0.71 mol of Pi released per mole of
enzyme/min.
Specificity of phosphate group cleavage
To determine if NS3 catalyzed the removal of one, two,
or three phosphate groups from the 5-triphosphate ter-
minus of the RNA substrate, the following experiments
were performed. First, NS3 was incubated with the same
triphosphorylated RNA substrate except that the -phos-
phate moiety was labeled with [32P]. The results showed
that the enzyme was unable to remove any labeled
[-32P] moiety from the RNA substrate, indicating that it
does not cleave the -phosphate-ribose ester linkage,
and must instead cleave the – or – phosphoric acid
anhydride bond(s) (Fig. 3A). Second, to determine which
phosphoric acid anhydride bond is cleaved by NS3, an
-32P-labeled RNA substrate was reacted with NS3. The
single G at the 5 end of the substrate RNA was then
cleaved by the addition of RNase T1 to the reaction and
the products were analyzed by TLC along with GTP, GDP,
and GMP standards. RNase T1 cleaves the phosphodi-
ester bond between the 3-guanylic acid group and the
5-hydroxyl group of the adjacent nucleotide (–Xp–
Gp–2Xp––) to the final product, –Xp–Gp (see Egami et
al., 1964); for example, upon RNase T1 treatment, cleav-
age of pppGp-RNA with a single G at the 5-end would
give rise to pppGp as the final product from the 5-
triphosphorylated RNA when not reacted with NS3 (Fig.
3B, lane “”). From the NS3-reacted substrate RNA,
either the ppGp or the pGp product is expected to be
produced by RNase T1 treatment, if the initial NS3 cleav-
age occurred at the – or – phosphoric anhydride
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bond, respectively. The results showed that the mobility
of the reaction product was similar to GTP (Fig. 3B, lane
“”), as one would expect if the NS3-catalyzed cleavage
event was specific to the – bond, to produce the
5-diphosphate G-3-monophosphate (5ppGp).
Analysis of RTPase activity of NS3 mutants
Based on the inhibition of the vaccinia virus 5-RTPase
activity by ATP, it was proposed that both ATPase and the
5-RTPase activities shared a common active site (My-
ette and Niles, 1996a). Moreover, in another report, a
proteolytically generated C-terminal WN NS3 polypep-
tide was reported to have divalent cation-independent
RTPase activity and metal ion-dependent NTPase activ-
ity. These characteristics and the identification of a con-
served motif 592LRPR (5-TRE) at the C-terminal region of
WN NS3 (67LKPR in vaccinia virus D1 protein) allowed the
authors to conclude that NTPase and RTPase have dif-
ferent active sites and that the 5-TRE might play an
important role in the RTPase activity (Wengler and Wen-
gler, 1993). In DEN2 NS3, the 5-TRE is 591LKPR. To
determine the involvement of the NTP-binding site and
the 5-TRE in RTPase activity in DEN2 NS3, the K199E,
L591A, and K592A NS3 mutants were generated and the
mutant proteins were expressed and partially purified.
Based on the level of purity, the wild-type and mutant
protein preparations were diluted to about the 2.8–3.7
nM range of concentrations in each RTPase assay as
indicated in Fig. 4. The NTP-binding-site mutation
(K199E), previously shown to abolish NTPase activity (Li
et al., 1999), was also shown in this study to result in
complete loss of RTPase activity, suggesting that the
RTPase and the NTPase activity of NS3 protein may
involve the same active site. Further experimental proof
was obtained as described below. The NS3 mutant pro-
teins containing the L591A and K592A substitutions in
the 5-TRE motif had RTPase activities comparable to the
wild-type protein (Fig. 4), indicating that the 5-TRE motif
is not likely involved in RTPase activity of the NS3 pro-
tein.
Effect of magnesium chloride on RTPase activity
To determine the divalent cation cofactor requirements
for the NS3 RTPase activity, assays were performed with
different MgCl2 concentrations. NS3 exhibited its maxi-
mum RTPase activity with no magnesium chloride
present and displayed concentration-dependent inhibi-
tion by MgCl2. At low MgCl2 concentrations only a very
modest inhibition was noted, but at the highest concen-
tration tested (10 mM), the RTPase activity was de-
creased by more than 50% (Fig. 5A).
Effect of EDTA on RTPase activity
The effect of EDTA on RTPase activity was assayed to
further examine the requirements of NS3 for divalent
cation cofactors. Assays were performed with various
EDTA concentrations in the presence of 1 mM magne-
sium chloride. A twofold excess of EDTA (2 mM) pro-
FIG. 1. Expression and purification of NS3 from E. coli. Conditions for
growth of E. coli transformed by the His-tagged NS3 expression plas-
mid and purification by metal-affinity (Talon resin) and gel-filtration
chromatographic steps are described under Materials and Methods.
The protein fractions were fractionated by SDS–PAGE (10%) and the
gels were stained by Coomassie blue. (A) Lane M, MW marker (kDa);
lane 2, soluble fraction of lysed E. coli; lane 3, supernatant from Talon
resin binding; lanes 6–29, Talon fractions 6, 9, 12, 15, 18, 22, 24 to 29.
An aliquot of 12 l was loaded in each lane. Lane marked as “Conc”
represents Centricon-concentrated Talon eluate. (B) Sephacryl S200
fractions 23–41. An aliquot of 22 l/lane was loaded, and after electro-
phoresis, the gels were stained with Coomassie blue and destained.
(C) SDS–PAGE (10%), followed by Coomassie blue staining of the final
NS3 protein products. Purified wild-type protein and partially purified
mutant proteins are shown here. The amounts of 10 l of wild-type
protein, 18 l of the K199E and K592A proteins, and 25 l of the L591A
protein were loaded. The relative purities, estimated by scanning of the
gels by a densitometer (Alpha Innotech Corp., San Leandro, CA), were
95% (wild type), 43% (K199E), 46% (K592A), and 38% (L591A), respec-
tively.
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duced little change in NS3 RTPase activity. At higher
EDTA concentrations, a marked concentration-depen-
dent inhibition of RTPase activity was noted (Fig. 5B). For
example, the activity was reduced from 60% in the control
or in the presence of 2 mM EDTA to 35% at 5 mM EDTA.
As shown in Fig. 5A, addition of MgCl2 also inhibited the
activity to a similar extent from 47% with no Mg2 to 25%
in the presence of 5 mM Mg2. Inhibition of RTPase
activity at higher concentrations of EDTA or Mg2 is
probably due to an increase in ionic strength. However,
that inhibition by EDTA is through chelation of the en-
zyme-bound metal ion that is required for RTPase activity
could not be ruled out. It was reported that in the 50-kDa
proteolytic fragment of WN NS3, the RTPase activity was
stimulated by the presence of 5 mM EDTA (Wengler and
Wengler, 1993). However, no stimulation of RTPase ac-
tivity by EDTA was observed for the full-length recombi-
nant DEN2 NS3 in this study. These results presented in
Fig. 5A and 5B, taken together, suggest that the RTPase
activity of DEN2 NS3 is divalent cation independent.
Effect of ionic strength on the RTPase activity
We previously demonstrated that the RNA-stimulated
NTPase activity of C-terminal NS3 polypeptide (contain-
ing amino acid residues 161 to 618) was sensitive to high
ionic strength. Based on this observation, we concluded
that the interaction of negatively charged RNA with the
enzyme for the stimulation of NTPase activity is ionic in
nature (Li et al., 1999). Since the RTPase activity of NS3
presumably involves interaction with the RNA substrate,
we sought to examine the effect of increasing ionic
strength (achieved by addition of KCl in RTPase assays).
The results shown in Fig. 5C indicate that maximum
RTPase activity was observed in the absence of KCl,
which decreased progressively with increasing concen-
trations of salt. Addition of KCl at 25 mM decreased the
RTPase activity by about 2-fold and was further reduced
by about 12-fold in reactions containing 150 mM or
greater KCl (Fig. 5C).
FIG. 2. The RNA 5-triphosphatase activity of NS3. The 5-RTPase activity of NS3 was dependent on incubation time and the assay was carried out
as described under Materials and Methods. This assay was repeated three times and similar results were obtained. (A) An autoradiogram of a
representative RTPase assay TLC plate is shown here. (B) The radioactivity of [32Pi] released was quantified by liquid scintillation counting and plotted.
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Effect of ATP and analogs on RTPase activity of NS3
To further investigate whether the same active site is
involved in the catalytic reactions of NS3 RTPase and
NTPase, assays were performed with different concen-
trations of ATP, ADP, AMP, and the poorly hydrolyzable
ATP analogs, adenylylimidodiphosphate (AMP-PNP) and
adenosine-5-O-(3-thiotriphosphate) (ATP--S). AMP, ADP,
and AMP-PNP were found to exert little or no effect on
RTPase activity, even at a concentration of 2.5 mM (Figs.
6A and 6B). However, ATP and ATP--S were found to
inhibit the NS3 5-RTPase activity in a concentration-
dependent manner. ATP--S was observed to be the
most potent inhibitor, reducing activity by about 2-fold at
a concentration of 0.5 mM and 14-fold at a concentration
of 2.5 mM. ATP was further examined as a physiologi-
cally relevant RTPase inhibitor, at six different concen-
trations. The degree of inhibition was dependent upon
ATP concentration as shown in Fig. 6C.
DISCUSSION
The mechanism of 5-capping of flaviviruses is not
understood at present. In this study, the first detailed
biochemical characterization of the RTPase activity of
full-length recombinant DEN2 NS3 is reported. A previ-
ous study showed that the carboxy-terminal fragment of
subtilisin protease-digested WN virus NS3 having G168 at
its amino terminus had both NTPase and RTPase activ-
ities (Wengler and Wengler, 1991, 1993). The results of
that study suggest that the subtilisin cleavage occurred
in a flexible region of full-length NS3 that is located
between the N-terminal viral serine protease domain
and the C-terminal NTPase/RNA helicase domain. The
NTPase domain of the subtilisin proteolytic fragment of
WN NS3 is consistent with the results of our mapping
study which defined the boundary between the viral
serine protease domain (1 to 167 residues) and the
NTPase domain of full-length NS3 (Li et al., 1999). Full-
length NS3 was also active as an NTPase in the previ-
ously established enzyme-coupled spectrophotometric
assay system (Li et al., 1999; Warrener et al., 1993) (data
not shown), suggesting that the enzyme is likely to be
correctly folded.
The RTPase activity of the full-length NS3 is very likely
to be influenced by other protein factors. In support of
this notion, the NTPase activity associated with NS3 was
stimulated by NS5 (Cui et al., 1998). In flavivirus-infected
cells, NS3 exists as a complex with NS5 (Chen et al.,
1997; Johansson et al., 2001; Kapoor et al., 1995). NS5 is
a component of viral replicase having the RNA-depen-
dent RNA polymerase activity that is required for minus-
strand RNA synthesis (Ackermann and Padmanabhan,
2001; You and Padmanabhan, 1999). Since NS5 also has
conserved domains found in several 5-RNA methyl-
transferases (Koonin, 1993; Rozanov et al., 1992), al-
though this activity has not been demonstrated yet, it
suggests that the NS3/NS5 complex is also involved in
5-capping as well.
Most known RTPases fall into one of two categories.
The divalent cation-dependent RTPases of many DNA
viruses and fungi belong to the first category (e.g., yeast
Cet1p, baculovirus LEF-4, and vaccinia virus D1). The
DNA viral enzymes can cleave the -phosphate group of
triphosphorylated RNA as well as rNTP and dNTP (Shu-
man et al., 1980). The NTPase and the 5-RTPase reac-
tions are catalyzed by a single active site located within
the amino-terminal 545 residue region (Myette and Niles,
1996b; Yu and Shuman, 1996; for a review, see Shuman,
2000). The yeast RTPase is Mg2-ion dependent and can
hydrolyze the -phosphoryl group of triphosphorylated
RNA but cannot hydrolyze ATP; however, the -phospho-
ryl group of pppGP is removed although RNA substrates
with longer chain length are preferred (Itoh et al., 1984).
In the second category, the divalent-cation-inde-
pendent enzymes of mammals and other metazoa re-
quire the (I/V)HCXAGXGR(S/T)G phosphate-binding mo-
tif, which is conserved in the tyrosine phosphatase/dual
specificity protein phosphatase enzyme family. In the
protein tyrosine phosphatase family of enzymes, the
transfer of protein phospho-monoester substrate to the
thiolate of the cysteine in the motif results in the forma-
tion of a covalent phosphocysteine intermediate which is
subsequently hydrolyzed to release the phosphate moi-
FIG. 3. The cleavage specificity of NS3. (A) This autoradiogram of a
RTPase assay TLC plate illustrates the inability of NS3 to remove
radioactivity from a -32P-labeled substrate. It is able, however, to
release radioactivity from a -32P-labeled RNA molecule. This film
represents two assays performed under identical conditions, with sim-
ilar results. (B) This autoradiogram of a cleavage specificity assay TLC
plate shows the RNAse T1 digestion products of the -32P-labeled
substrate RNA, first either unreacted (“”) or reacted (“”) with NS3
prior to RNase T1 digestion. GTP, GDP, and GMP were used as
standards, and their migration distances are indicated at the left side
margin. This experiment was repeated twice and similar results were
obtained. The detailed procedure for this assay is described in the text.
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ety. The metazoan RTPases having the same conserved
motif cleave the – phosphoric anhydride bond. These
enzymes do not catalyze the same cleavage in nucleo-
side triphosphate substrates (Takagi et al., 1997; Yagi et
al., 1983). However, a recent structural and mechanistic
study on the mouse RTPase revealed that the enzyme
hydrolyzes ATP with a pH optimum of 5.0, although it has
little activity at pH 7.0 (Changela et al., 2001). However,
although the RTPase activity of DEN2 NS3 protein is
cation independent, it has a well-documented NTPase
activity with a pH optimum of 7.5 in the presence of
poly(A) (Li et al., 1999). The apparent absence of a diva-
lent cation requirement for the 5-RTPase activity and
established metal ion-dependent NTPase activity sug-
gest that flavivirus NS3 does not fit well into either of the
established categories of RNA triphosphatases. Flavivi-
rus NS3 RTPases may comprise a distinct family of
positive-strand RNA virus RTPases. No detailed struc-
tural or mechanistic information is currently available for
the DEN2 NS3 RTPase.
Analysis of NS3 substitution mutant proteins provided
insight into domains of NS3 that are important for the
RTPase function. The nucleoside triphosphate-binding
site mutant (K199E) was not an active 5-RTPase (this
study). Our previous study showed that this mutation
also abolished the NS3 NTPase activity (Li et al., 1999),
suggesting that the same active site used for the NS3
NTPase function is also essential for 5-RTPase activity.
Moreover, the conserved 5-TRE motif was identified in
another study, based on a multiple amino acid sequence
alignment of several flavivirus NS3 C-terminal regions
showing 590KILRPRW, to be important for 5-RTPase ac-
tivity (Wengler and Wengler, 1993). The vaccinia virus D1
protein that contains both 5-RTPase and guanylyltrans-
ferase active domains also has a 67ILKPR sequence
(Wengler and Wengler, 1993). However, mutational anal-
ysis of the vaccinia virus D1 RTPase indicated that amino
acid residues corresponding to the flavivirus 5-TRE
identified previously (Wengler and Wengler, 1993) are not
essential for vaccinia virus RTPase activity (Yu et al.,
1997). However, the contribution of the 5-TRE motif, if
any, for the flavivirus 5-RTPase has not been analyzed to
date by mutagenesis. In this study, our results show that
the RTPase activities of the 5-TRE mutant proteins
(L591A and K592A) possess RTPase activity comparable
to that of the wild-type protein. Given that these mutant
proteins were not completely purified, an estimation of
NS3 purity was required. This estimation makes precise
quantitation of the activities of the mutant proteins diffi-
cult. Nonetheless, with this potential source of error
taken into account, our results indicated that the 5-TRE
mutations did not produce a dramatic effect in RTPase
activity, and hence the 5-TRE apparently does not func-
tion as a distinct RTPase active site in DEN2 NS3.
In the case of Semliki Forest virus Nsp2, the RTPase
activity was also abolished by mutation of the NTP-
binding site. However, the RTPase activity was stimu-
lated by the presence of GTP, which led the authors to
FIG. 4. The RTPase activity of mutant NS3 proteins. From the estimations of protein concentrations of final NS3 proteins and the relative purities
of wild-type and mutant NS3 proteins, the enzyme preparations were diluted 1:50 (wild type; 3.7 nM), 1:8.55 (K199E; 3.3 nM), 1:6.4 (L591A; 3.1 nM),
and 1:4.65 (K592A; 2.8 nM). The assays were carried out in triplicate. The plot shown here illustrates the relative RTPase activities of the wild-type
enzyme and three point mutants.
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propose the probable existence of a separate RTPase
active site (Vasiljeva et al., 2000). This explanation seems
much less likely for DEN2 NS3 given the fact that ATP
acts as an inhibitor of RTPase activity. To determine
whether NTPase and RTPase reactions are catalyzed by
separate active sites or by the same active site, several
ATP analogs were assayed for their ability to inhibit
RTPase activity. If the NTPase and RTPase activities are
carried out at a common active site, ATP would be
expected to act as a competitive inhibitor of RTPase
activity. Our results showed that ATP acted as a concen-
tration-dependent RTPase inhibitor. Levels as low as 0.1
mM ATP inhibited RTPase activity by almost one-third.
FIG. 5. The effects of MgCl2, EDTA, and KCl, on RTPase activity. (A)
Effect of MgCl2. This plot illustrates the effect of varying MgCl2 con-
centration on RTPase activity. The assay was incubated for 10 min at
25°C. RTPase assays in the presence of 0, 1, and 2 mM MgCl2 were
repeated three times and in the presence of 5 and 10 mM MgCl2 twice
and similar results were obtained. (B) Effects of EDTA. This plot illus-
trates the effect of varying concentrations of EDTA on RTPase activity of
NS3. These assays were performed in the presence of 1 mM MgCl2.
Duplicate time course in the presence of 0, 2, and 5 mM EDTA and a
single time course in the presence of 10 and 25 mM EDTA were
conducted. (C) Effect of KCl. This plot illustrates the effect of varying KCl
concentrations on NS3 RTPase activity. The assay was incubated for 10
min at 25°C. This experiment was repeated twice with similar results.
FIG. 6. The inhibition of NS3 RTPase activity by ATP and other
nucleotide analogs. (A and B) These plots illustrate the effect of includ-
ing various nucleotide analogs on the RTPase activity at a concentra-
tion of 0.5 and 2.5 mM, respectively. (C) This plot illustrates the effect of
varying ATP concentrations on NS3 RTPase activity expressed as % Pi
removed at a 15-min incubation time. This experiment was repeated
twice and the average values were plotted.
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Higher ATP concentrations were able to significantly
inhibit the RTPase activity. This inhibition is unlikely due
to chelation of Mg2 ion by ATP as we have shown that
metal ion is not required for RTPase activity. However,
the possibility that inhibition of RTPase by ATP is through
chelation of enzyme-bound metal ion has not been ruled
out.
In addition, two ATP structural analogs, adenylyl-imi-
dodiphosphate and adenosine-5-O-(3-thiotriphosphate),
were tested for their ability to inhibit the RTPase activity
of NS3. AMP-PNP is a good substrate for enzymes hy-
drolyzing the bond between the - and the -phospho-
rous atoms, but is resistant to enzymes cleaving the –
bond. ATP--S is hydrolyzed very inefficiently by most
phosphatases. Our results showed that AMP-PNP was
not an effective inhibitor, likely because it was unable to
bind to the NS3 substrate-binding site. However, ATP--S
proved to be an even more potent RTPase inhibitor than
ATP. As expected, AMP and ADP were unable to inhibit
RTPase activity. ADP is the product of the ATPase reac-
tion, and therefore would be expected to have a lower
affinity than ATP for the same binding site. AMP appears
to be largely physiologically irrelevant with respect to the
RTPase and NTPase enzymatic reactions.
Maximum RTPase activity was observed in the ab-
sence of KCl, with decreasing activity as [KCl] was in-
creased. Increasing ionic strength likely inhibits ionic
interactions between the substrate RNA molecule and
the NS3. It was previously reported that the RNA stimu-
lation of the DEN2 NS3 ATPase was also inhibited by an
increase in ionic strength (Li et al., 1999). RNA and
phosphate group binding events are well known to often
be dependent on ionic interactions, so it is not surprising
that high ionic strength disrupts RTPase function. This
single-stranded RNA-protein interaction may alter NS3
structure in a way that allows an increase in the rate of
nucleoside triphosphate hydrolysis. NS3 may also bind
to RNA molecules by interacting with 5-triphosphate
termini (rather than just the polynucleotide backbone),
thereby causing the substrate to assume a position that
allows phosphoric acid anhydride bond cleavage to oc-
cur. Although the same substrate-binding site (G198 K T) is
essential for NTPase and RTPase reactions, other do-
mains, perhaps involved in RNA binding, may influence
catalysis at this site.
More structural data for NS3 are necessary to under-
stand the RTPase reaction mechanism and the nature of
the NTPase/RTPase active site. The crystal structure of
NS3 would prove quite useful in providing a better un-
derstanding of its multiple enzymatic reactions, as well
as aid in the development of RTPase inhibitors. Drugs
that inhibit the RNA capping enzymes could halt viral
replication and prove to be clinically useful for the treat-
ment of illnesses caused by flaviviruses.
MATERIALS AND METHODS
Construction of 6His-NS3 expression plasmid
The pQE30(UA)-NS3(185) plasmid (Murthy et al., 1999)
was digested with the restriction enzymes NcoI and NsiI,
resulting in the release of the desired 2949 nt vector
fragment. The pLZ3 plasmid (Zhang et al., 1992) was
digested with NsiI and HincII, resulting in the release of
the 1694 nt insert. The 3-recessed end created by the
digestion of the 2949 nt fragment from pQE30(UA)-
NS3(185) with NcoI was filled in by reaction with the
Klenow fragment of DNA polymerase I. After phosphor-
ylation of the 1694 nt insert with T4 polynucleotide kinase
and dephosphorylation of the vector fragment with calf
intestinal alkaline phosphatase (CIP), the ligation reac-
tion was performed. The integrity of the resulting pQE30-
NS3 plasmid was confirmed by sequencing. This plas-
mid encodes a N-terminal 6  His tag and the full-length
DEN2 NS3 protein under the control of the lac promoter,
which is inducible with IPTG.
Construction of NS3 point mutants
Site-directed mutagenesis was performed utilizing a
PCR-based technique (Higuchi et al., 1988). For K199E,
PCR was performed utilizing the pQE30-NS3 plasmid as
the template with the following primers: 5GKT (4841–
4862 nt), 3GKT (complement of 5223–5243 nt), K199Ea,
and K199Eb (5109–5128 nt and its complement contain-
ing the desired mutation AAG 3 GAG). PCR was per-
formed in separate reactions containing the 5GKT and
K199Eb primers and the 3GKT and K199Ea primers,
respectively. The 5PCR product (290 nt) and the 3PCR
product (135 nt) were purified and used together as
templates for a final reaction with the 5GKT and 3GKT
primers. The PCR fragment was phosphorylated by treat-
ment with T4 polynucleotide kinase. The pSP64 vector
plasmid was linearized by digestion with SmaI and de-
phosphorylated by treatment with calf intestinal phos-
phatase (Promega). The phosphorylated PCR fragment
was ligated to the dephosphorylated vector plasmid and
the mixture was used to transform E. coli (XL1-Blue). The
pSP64 intermediate plasmid clone containing the PCR
product was obtained and digested with Bsu36I to excise
a 240 nt fragment containing the desired mutation site.
This mutant Bsu36I fragment was switched with the
corresponding wild-type fragment from the pQE30-NS3
plasmid, giving rise to the pQE30-NS3 K199E expression
plasmid.
For construction of the L591A-NS3 mutant plasmid, the
following primers were used: 1 (5815–5838 nt), 2 (921–
940 nt in pQE30-UA vector; Qiagen), L591A-a, and
L591A-b (6280–6305 nt and its complement, respec-
tively). PCR was performed utilizing pQE30-NS3 as the
template with primers 1 and L591A-b and primers 2 and
L591A-a, respectively. The resulting fragments (491 nt
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and 152 nt, respectively) were then used as templates for
PCR with primers 1 and 2, resulting in a 617 nt final PCR
product. This PCR product was phosphorylated with T4
polynucleotide kinase and ligated into the plasmid
pSP71 (Promega) after linearization of the plasmid with
PvuII and CIP treatment. The sequence of the PCR frag-
ment was verified. The intermediate plasmid and pQE30-
NS3 were digested with PpuMI and NcoI, resulting in the
release of a 540 nt fragment containing the desired
mutation site. The large vector fragment from pQE30-
NS3 and the mutated 540 nt fragment from the pSP71
intermediate plasmid were purified and ligated.
For construction of the K592A-NS3 mutant plasmid, the
same procedure was followed with the exception of the
substitution of K592A-a and K592A-b primers (6284–6308
nt containing AAA3 GCA mutation and its complement)
for L591A-a and L591A-b primers, respectively. Plasmid
constructs were sequenced to confirm the presence of
the desired mutations.
NS3 expression and purification
Competent E. coli XL1-Blue were transformed with the
pQE30-NS3 expression vectors and grown in 500 ml of
LB liquid medium containing 100 g/ml ampicillin and
0.5% (w/v) glucose. This culture was incubated with
shaking at 37°C until the absorbance of the culture at
600 nm reached 0.6. Cells were centrifuged in a Sorvall
H6000 rotor at 5000 g for 10 min and resuspended in
another flask containing 500 ml of LB with ampicillin and
0.5 mM IPTG. This flask was incubated at 30°C for 3 h
and cells were harvested by centrifugation as previously
described. The cell pellet was resuspended in 40 ml of
cold lysis buffer (50 mM sodium phosphate, pH 7.1, 300
mM NaCl, 1% NP-40, 1X Roche complete protease inhib-
itor cocktail without EDTA). Cells were lysed by French
press. The lysate was centrifuged at 4°C for 35 min at
12,000 g in a Sorvall SS34 rotor to remove insoluble
materials. All of the following steps were performed at
4°C or on ice. Clarified lysate was incubated with 1.75 ml
of preequilibrated Talon metal-affinity resin (Clontech) for
2 h. After removal of the supernatant, the resin was
washed four times with 12 ml of wash buffer (purification
buffer lacking protease inhibitor). The affinity resin was
then applied to a 0.8  4 cm column (Bio-Rad) and
washed with 25 ml of wash buffer, followed by 10 ml of
wash buffer containing 25 mM imidazole. Remaining
proteins were then eluted in 0.5 ml fractions from the
column with the wash buffer containing 150 mM imida-
zole. Those 0.5-ml fractions containing pure protein were
pooled and concentrated to a final volume of approxi-
mately 0.7 ml with a Centricon YM-30 ultrafiltration spin
column (Millipore) by centrifuging for 40 min at 4200 g in
a Sorvall SS34 rotor. The NaCl concentration was ad-
justed to 1 M by adding 5 M NaCl slowly and with mixing.
Gel-filtration chromatography was performed in a 1 
50-cm glass column (Bio-Rad) packed with Sephacryl
S200 resin (Amersham Pharmacia) with a running buffer
consisting of 50 mM sodium phosphate, pH 7.1, 1 M NaCl.
Those 0.3-ml fractions indicated by SDS–PAGE and Coo-
massie blue staining to contain the purified NS3 were
pooled and dialyzed against 20 mM Tris, pH 7.5, 75 mM
NaCl, 40% glycerol. Collodion membranes (Schleicher
and Schuell) with a molecular weight cutoff of 10,000 Da
were used for dialysis. The purified NS3 protein was then
aliquoted and stored at 20°C.
Preparation of the substrate for the RTPase assay
Equimolar amounts of the following DNA oligonucleo-
tides (5-TTA CGA ATT CGA GCT CGC CCT AAT ACG
ACT CAC TAT AG-3 and 5-AGT GAA TGG AGT TGA GTA
TGC TAT AGT GAG TCG TAT TAG GGC GAG CTC GAA
TTC GTA A-3) were annealed in a water bath in the
presence of 20 mM Tris-HCl, pH 8.0, and 50 mM NaCl.
The underlined sequence constitutes the T7 promoter.
These annealed oligonucleotides were used as the tem-
plate for an in vitro transcription reaction (Milligan et al.,
1987) in the presence of 40 Ci of either -[32P]- or
-[32P]GTP (6000 Ci/mmol, NEN-Perkin Elmer Research
Products), resulting in a 21 nucleotide RNA molecule
with a single -32P- (or -32P)-labeled G at the 5-end.
After acid phenol/chloroform and chloroform extractions,
the RNA was precipitated with 0.1 vol of 3 M sodium
acetate pH 5.2 and 2.5 vol of ethanol. This pellet was
resuspended in nuclease-free water and passed through
a Bio-Rad P6 column to remove unincorporated radioac-
tive GTP. After another ethanol precipitation, the pellet
was dissolved in 20–30 l of nuclease-free water and
stored at 90°C. The RNA concentration was deter-
mined by measuring absorbance at 260 nm and visual-
ized by electrophoresis on a 4% polyacrylamide-urea gel
and autoradiography.
RNA triphosphatase assay
The RNA triphosphatase assay was performed as de-
scribed (Tutas and Paoletti, 1977; Venkatesan et al., 1980)
with several modifications. The standard reaction mix-
ture contained 25 mM Hepes-K, pH 7.5, 1 mMMgCl2, 0.1
g/l BSA, 1 unit/l RNasin, 6–60 nM -32P-labeled RNA
substrate, and 2.5–10 nM purified NS3. Assays were
carried out in a constant temperature block at 25°C.
Typically, 10-l aliquots were removed from the 100-l
reaction mixture at specific time points and added to a
tube containing 1 l of 0.5 M EDTA and placed on ice to
stop the reaction. An aliquot (7.5 l) of each sample was
spotted onto a polyethyleneimine cellulose thin-layer
chromatography (TLC) plate. After air drying, the plate
was developed in water for 1 min and then placed in a
TLC chamber containing 0.75 M potassium phosphate
(pH 3.4). The plate was air-dried and the samples were
analyzed by autoradiography. The autoradiogram was
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then matched to the TLC plate so that radioactive spots
could be excised and quantified by liquid scintillation
counting. The radioactive spots at the origin (RNA sub-
strate) and those corresponding to released [32Pi] were
placed in a 5-ml scintillation vial containing ScintiSafe
Econo2 fluid (Fisher) and counted for 5–15 min with a
Packard Tri-Carb 2900TR liquid scintillation counter. The
percent of -phosphates released by the NS3 RNA
triphosphatase activity was calculated.
Cleavage specificity assay
The RNA triphosphatase cleavage specificity assay
(Vasiljeva et al., 2000; Venkatesan et al., 1980) was per-
formed in a 10-l reaction volume. An -32P-labeled RNA
substrate was reacted with NS3 protein for 30 min under
standard assay conditions. EDTA was added to a final
concentration of 4.5 mM. RNase T1 (100 units/ml; Roche)
was then added and the incubation was continued for 90
min at 30°C. Aliquots (7.5 l) of reactions (with and
without enzyme addition) were spotted along with 7.5 l
each of 10 mM GTP, 10 mM GDP, and 10 mM GMP
standards onto a PEI cellulose TLC plate. The plate was
developed in 1 M lithium chloride and analyzed by auto-
radiography. Mobilities of GTP, GDP, and GMP standards
were visualized by short-wavelength ultraviolet illumina-
tion.
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